Oral d-fenfluramine test in treatment-refractory depression: Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group

Journal of Affective Disorders

Volumn 57, Issue 1-3, 2000, Pages 201-208

  Prochazka, Helena ^a   Sjögren, Magnus ^a   Ågren, Hans ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Fenfluramine; Major depression; Prolactin; Serotonin; Suicide; Treatment refractory depression

Indexed keywords

DEXFENFLURAMINE; PROLACTIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROVOCATION TEST; SEROTONINERGIC SYSTEM; SUICIDE ATTEMPT; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; AGED; BODY MASS INDEX; CHRONIC DISEASE; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FENFLURAMINE; HUMANS; MALE; MIDDLE AGED; PROLACTIN; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SUICIDE, ATTEMPTED;

EID: 0343114505     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(99)00094-4     Document Type: Article

References (25)

1. Ågren H. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the CSF: suicide. Psychiatry Res. 3:1980;225-236.
2. Ågren H. Life at risk: Markers of suicidality in depression. Psychiatr. Devel. 1:1983;87-104.
3. Depressive disorders. Quick Reference to the Diagnostic Criteria from DSM-IV. 4th ed. 1994;167-172 American Psychiatric Press, Washington, DC.
4. Åsberg M., Träskman L., Thorén P. 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Arch. Gen. Psychiatry. 33:1976;1193-1197.
5. Brown G., Ebert M., Goyer P., Jimerson D., Klein W., Bunney W., Goodwin F. Aggression, suicide, and serotonin: relationship to CSF amine metabolites. Am. J. Psychiatry. 139:1982;741-746.
6. Carlton J., Rowland N. Long term actions of d-fenfluramine in two rat models of obesity. I. Sustained reductions in body weight and adiposity without depletion of brain serotonin. Int. J. Obesity. 13:1989;825-847.
7. Cleare A., Murray R., O'Keane V. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects. Neuropsychopharmacology. 14:1996;349-354.
8. Coccaro E., Siever L., Klar H., Maurer G., Cochrane K., Cooper T., Mohs R., Davis K. Serotonergic studies in patients with affective and personality disorders. Arch. Gen. Psychiatry. 46:1989;587-599.
9. Coccaro E., Kavoussi R.J., Cooper T.B., Hauger R.L. Central serotonin activity and aggression: Inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. Am. J. Psychiatry. 154:1997;1430-1435.
10. d'Elia G., Perris C. Selbstmordversuche im Laufe unipolarer und bipolarer Depressionen. Arch. Psychiat. Nervenkr. 212:1969;339-356.
11. Endicott J., Cohen J., Fleiss J., Sarantakos S. Hamilton Depression Rating Scale extracted from regular and changed versions of the Schedule for Affective Disorders and Schizophrenia. Arch. Gen. Psychiatry. 38:1981;98-103.
12. Fuxe K., Farnebo L., Hamberger B., Ögren S. On the in vivo and in vitro actions of FEN and its derivates on central monoamine neurons especially, 5-hydroxytryptamine neurons, and their relation to the anorectic activity of fenfluramine. Postgrad. Med. J. 51:(suppl. 1):1975;35-45.
13. McNeilly A.S. Radioimmunoassay of human prolactin. Proc. R. Soc. Med. 66:1973;863-864.
14. Mann J., McBride P., Brown R., Linnoila M., Leon A., DeMeo M., Mieczkowski T., Myers J., Stanley M. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch. Gen. Psychiatry. 49:1992;442-446.
15. Mann J., McBride P., Malone K., DeMeo M., Keilp J. Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacology. 13:1995;53-64.
16. Muldon M., Kaplan J., Manuck S. Effects of dietary fat on central nervous system serotonergic activity. Am. Psychosom. Soc. 53:1991;216.
17. Norusis M. SPSS Base System User's Guide. 1990;SPSS Inc, Chicago.
18. O'Keane V., Dinan T. Prolactin and cortisol responses to d-fenfluramine in major depression: Evidence for diminished responsivity of central serotonergic function. Am. J. Psychiatry. 148:1991;1009-1015.
19. O'Keane V., Hanlon M., Webb M., Dinan T. d-Fenfluramine/prolactin response throughout the menstrual cycle: Evidence for an oestrogen-induced alteration. Clin. Endocrinol. 34:1991;289-292.
20. Quattrone A., Tedeschi G., Aguglia U., Scorpacasa F., DiRenzo G., Annunziato L. Prolactin secretion in man: a useful tool to evaluate the activity of drugs acting on central 5-hydroxytryptaminergic neurones: studies with fenfluramine. Br. J. Clin. Pharmacol. 16:1983;471-475.
21. Schalling, D., Edman, G., 1993. The Karolinska Scales of Personality (KSP): An inventory for assessing temperament dimensions associated with vulnerability for psychosocial deviance. Karolinska Institute, Department of Psychiatry, Stockholm.
22. Siever L., Murphy D., Slatera Vega E., Lipper S. Plasma prolactin changes following fenfluramine in depressed patients compared with controls: an evaluation of central serotonergic responsivity in depression. Ann. New York Acad. Sci. 34:1984;1029-1039.
23. Spitzer R., Endicott J. Schedule for Affective Disorders and Schizophrenia. 1978;New York State Psychiatric Institute, New York.
24. Träskman L., Åsberg M., Bertilsson L., Sjöstrand L. Monoamine metabolites in CSF and suicidal behaviour. Arch. Gen. Psychiatry. 38:1981;631-636.
25. Yatham L., Steiner M. Neuroendocrine probes of serotonergic function: A critical review. Life Sci. 53:1993;447-463.